<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Trost BM</submitter><funding>NIGMS NIH HHS</funding><pagination>6054-5</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2585983</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>128(18)</volume><pubmed_abstract>New classes of nucleophiles, pyrroles, and N-methoxyamides were developed for Pd-catalyzed AAA reactions. By varying the functional groups at the 2-position of pyrroles, either regioisomer of the piperazinone is available. Using one regioisomer, the total synthesis of (+)-agelastatin A in 10 total steps is accomplished. For this synthesis, a new copper-catalyzed aziridination and an indium-catalyzed oxidative ring opening of a N-tosylaziridine were developed. The feasibility of accessing (-)-agelastatin A from the same enantiomer of the chiral catalyst from the other regioisomeric piperazinone is indicated.</pubmed_abstract><journal>Journal of the American Chemical Society</journal><pubmed_title>New class of nucleophiles for palladium-catalyzed asymmetric allylic alkylation. Total synthesis of agelastatin A.</pubmed_title><pmcid>PMC2585983</pmcid><funding_grant_id>R01 GM013598-42</funding_grant_id><funding_grant_id>GM13598</funding_grant_id><funding_grant_id>R01 GM013598</funding_grant_id><pubmed_authors>Dong G</pubmed_authors><pubmed_authors>Trost BM</pubmed_authors></additional><is_claimable>false</is_claimable><name>New class of nucleophiles for palladium-catalyzed asymmetric allylic alkylation. Total synthesis of agelastatin A.</name><description>New classes of nucleophiles, pyrroles, and N-methoxyamides were developed for Pd-catalyzed AAA reactions. By varying the functional groups at the 2-position of pyrroles, either regioisomer of the piperazinone is available. Using one regioisomer, the total synthesis of (+)-agelastatin A in 10 total steps is accomplished. For this synthesis, a new copper-catalyzed aziridination and an indium-catalyzed oxidative ring opening of a N-tosylaziridine were developed. The feasibility of accessing (-)-agelastatin A from the same enantiomer of the chiral catalyst from the other regioisomeric piperazinone is indicated.</description><dates><release>2006-01-01T00:00:00Z</release><publication>2006 May</publication><modification>2025-04-05T11:51:59.712Z</modification><creation>2019-03-26T23:28:29Z</creation></dates><accession>S-EPMC2585983</accession><cross_references><pubmed>16669672</pubmed><doi>10.1021/ja061105q</doi></cross_references></HashMap>